Hope Rugo· @hoperugo · X·· 2 天前评分90
正文 · 原文
@myesmo #ESMO26. The start to an exciting meeting - first two oral BC sessions today. The first session with OS data from Natalee, long term benefit from extended letrozole in B42, huge benefits from 3 novel ADCs in HER2 low/HR+ & Talent. @OncoAlert
872 浏览 · 16 赞 · 6 转发 · 0 回复
会议摘要
LBA25按 Proffered paper 1: Breast cancer, early and advanced stage 对上
Adjuvant ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+/HER2− early breast cancer (EBC): NATALEE 6-y overall survival (OS) and efficacy outcomes
https://esmocongress.esmo.orgOpening ceremony at #ESMO26 #ESMO26 #ESMOAmbassadors #ESMOcommunity @myESMO在 X 查看被引用的帖子
来源:Hope Rugo · x.com
